AVNS AVANOS MEDICAL, INC.

8-K Current Report

Filed: March 12, 2026

Health Care

Orthopedic, Prosthetic & Surgical Appliances & Supplies

AVANOS MEDICAL, INC. (AVNS) 8-K current report filed with SEC EDGAR on March 12, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 5.02: Departure/Election of Directors or Officers

AI Filing Analysis
8-K

Item 5.02 · Departure/Election of Directors or Officers

• CEO David Pacitti's annual LTI grant target raised 10% from $5,000,000 to $5,500,000, effective 2026
• Increase signals Board confidence in Pacitti's leadership; adds $500K annual equity cost to compensation expense

+1 more insights

Other AVANOS MEDICAL, INC. 8-K Filings

8-K Feb 26, 2026

8-K Feb 24, 2026

Get deeper insights on AVANOS MEDICAL, INC.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.